Granules India Ltd
General
Total Cases7
Active Cases--
Patents3
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 10/16/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,155,705; 9,415,016; 10,022,379; 10,973,827 ; 11,911,388. (Attachments: # [1] NOTICE of Voluntary Dismissal)(kmd) (Entered: 10/16/2024) | |
| 10/16/24 | CONSENT JUDGMENT in favor of Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. against Granules India Limited. Signed by Judge Colm F. Connolly on 10/16/2024. (kmd) (Entered: 10/16/2024) | |
| 10/16/24 | CASE CLOSED per [8] NOTICE of Voluntary Dismissal. (kmd) (Entered: 10/16/2024) | |
| 10/07/24 | PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/07/2024) | |
| 10/07/24 | NOTICE of Voluntary Dismissal by Boehringer Ingleheim International GMBH, Boehringer Ingleheim Pharma GMBH & Co. KG, Boehringer Ingleheim Pharmaceuticals Inc. (Dellinger, Megan) (Entered: 10/07/2024) | |
| 10/02/24 | STANDING ORDER REGARDING BRIEFING IN ALL CASES. Signed by Judge Colm F. Connolly on 10/2/2024. (mws) (Entered: 10/02/2024) | |
| 10/02/24 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 10/02/2024) | |
| 10/01/24 | Summons Issued as to Granules India Limited. (scs) (Entered: 10/01/2024) | |
| 10/01/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Pharmaceuticals Inc. Filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG. (scs) (Entered: 10/01/2024) | |
| 10/01/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,155,705 B2; 9,415,016 B2; 10,022,379 B2; 10,973,827 B2 ; 11,911,388 B2. (scs) (Entered: 10/01/2024) |